| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2021―Dec―29 |
Can Our Success with HIV Serve as a Guide for Antiviral Drug Development for Covid-19? |
|
| 2 |
[GO] |
2021―Oct―13 |
Studies Differ on Efficacy of COVID-19 Convalescent Plasma Treatments |
|
| 3 |
[GO] |
2021―Oct―13 |
GWAS Reveals Multiple Host Genes Linked to Severe COVID-19 Symptoms |
|
| 4 |
[GO] |
2021―Oct―13 |
T Cells from Previous Coronavirus Infections Lead to Milder COVID-19 Symptoms |
|
| 5 |
[GO] |
2021―Oct―13 |
Airway Immune Cell Differences with Age May Explain Milder COVID-19 Symptoms in Children |
|
| 6 |
[GO] |
2021―Oct―13 |
SARS-CoV-2 Shows Tremendous Capacity to Adapt and Change |
|
| 7 |
[GO] |
2021―Oct―13 |
One-Hour Saliva-Based SARS-CoV-2 Test Developed |
|
| 8 |
[GO] |
2021―Aug―26 |
Antibody-Producing Cells Last At least One Year After COVID-19 Infection |
|
| 9 |
[GO] |
2021―Aug―26 |
Disappointing Late-Stage Results for CureVac's COVID-19 mRNA Vaccine Trial |
|
| 10 |
[GO] |
2021―Aug―26 |
Portable Saliva-Based COVID-19 Test is Quick, Accurate and Sensitive |
|
| 11 |
[GO] |
2021―Aug―26 |
NIH Begins COVID-19 Vaccine Booster Shot Trials |
|
| 12 |
[GO] |
2021―Aug―26 |
SARS-CoV-2 Reproductive Method Could Be Good Target for Therapies |
|
| 13 |
[GO] |
2021―Aug―26 |
Sequencing and COVID-19 From Genomic Epidemiology to Host Response: Nanopore sequencing technology has been central to understanding the biology and spread of SARS-CoV-2 |
|
| 14 |
[GO] |
2021―Aug―26 |
Powering Diagnostics for Infectious Disease: The COVID-19 pandemic saw a rush of companies developing diagnostics for the infectious disease that should benefit the detection of other diseases |
Malorye Allison Branca |
| 15 |
[GO] |
2021―Aug―26 |
Variants: Preferential Expression of Immune Suppressive Genes Contributes to SARS-CoV-2 increased Transmission and Virulence |
|
| 16 |
[GO] |
2021―Jun―18 |
Impact of Epigenetics on COVID-19 |
|
| 17 |
[GO] |
2021―Jun―18 |
Leprosy Drug Shows Potential as At-Home Treatment for COVID-19 |
|
| 18 |
[GO] |
2021―Jun―18 |
Common IBD Treatment Reduces Immune Response to COVID-19 |
|
| 19 |
[GO] |
2021―Jun―18 |
Epigenetic Factors Predicting More Severe COVID-19 Revealed |
|
| 20 |
[GO] |
2021―Jun―18 |
Sussing Out COVID-19 Severity: Can genetic variability explain why some people become seriously ill with COVID-19 while others have only mild illness? |
Helen Albert |
| 21 |
[GO] |
2021―Jun―18 |
J&J COVID-19 Vaccine Pause Ended After Blood Clot Scare |
|
| 22 |
[GO] |
2021―Jun―18 |
Study Will Assess Reasons for Allergic Reactions to Moderna, Pfizer/BioNTech COVID-19 Vaccines |
|
| 23 |
[GO] |
2021―Jun―18 |
U.S. Slow to Sequence, Track SARS-CoV-2 Variants |
|
| 24 |
[GO] |
2021―Apr―09 |
Lilly COVID-19 Antibody Combination Gets Emergency Use Authorization from FDA |
|
| 25 |
[GO] |
2021―Apr―09 |
Long-Term Effects of COVID-19 Infection Detailed in New Study |
|
| 26 |
[GO] |
2021―Apr―09 |
The Race for a Smart Phone-Based COVID-19 Test Heats Up |
Malorye Allison Branca |
| 27 |
[GO] |
2021―Apr―09 |
Precisely, With William Haseltine, Ph.D.: Seasonal Population Immunity Is a Better Description for COVID-19 than “Herd” Immunity |
|
| 28 |
[GO] |
2021―Apr―09 |
Novavax and Janssen Report Positive Phase III Results for COVID-19 Vaccine Candidates |
|
| 29 |
[GO] |
2021―Apr―09 |
Some COVID-19 Vaccines More Effective Against New Strains Than Others |
|
| 30 |
[GO] |
2021―Apr―09 |
CRISPR-Based Tests Allows Fast, Accurate SARS-CoV-2 Identification |
|
| 31 |
[GO] |
2021―Feb―12 |
Llama Nanobody Shows Promise as Treatment for COVID-19 |
|
| 32 |
[GO] |
2021―Feb―12 |
Sniffing out COVID-19 |
|
| 33 |
[GO] |
2021―Feb―12 |
Patient Care During COVID-19: Lessons from monitoring transplant patients in the age of COVID-19 and deployment of molecular diagnostics in vulnerable populations |
Peter Maag |
| 34 |
[GO] |
2021―Feb―12 |
New Study Suggests COVID-19 Lung Damage Reduced in Patients Prescribed Fenofibrate |
|
| 35 |
[GO] |
2021―Feb―12 |
Gingko Bioworks Pilots Pooled COVID-19 Testing for Schools |
|
| 36 |
[GO] |
2021―Feb―12 |
Critical COVID-19 Testing Issues |
|
| 37 |
[GO] |
2021―Feb―12 |
Rapid SARS-CoV-2 testing: LAMP and antigen COVID-19 tests promise inexpensive, accurate, and fast results to help manage the pandemic |
Helen Albert |
| 38 |
[GO] |
2021―Feb―12 |
Most Healthcare Workers Have Low SARS-CoV-2 Infection Risks at Work |
|
| 39 |
[GO] |
2021―Feb―12 |
Evidence Suggests SARS-CoV-2 Spike Protein Can Enter the Brain |
|
| 40 |
[GO] |
2021―Feb―12 |
At-Home SARS-CoV-2 Test From DxTerity to be Sold Through Amazon |
|
| 41 |
[GO] |
2021―Feb―12 |
Still in the Grips of the Pandemic |
Chris Anderson |
| 42 |
[GO] |
2021―Feb―12 |
Mental Health is Diagnostic Pandemic Ready |
|
| 43 |
[GO] |
2020―Dec―04 |
NIH Launches COVID-19 Clinical Trial of Immune Modulators |
|
| 44 |
[GO] |
2020―Dec―04 |
Baylor Genetics Launches At-Home COVID-19 Collection Kit |
|
| 45 |
[GO] |
2020―Dec―04 |
NIH Grants $234M to Expand Testing for COVID-19 in Minority Communities |
|
| 46 |
[GO] |
2020―Dec―04 |
Testing Conundrum: The rapid roll-out of COVID-19 testing has lawmakers and stakeholders wrestling anew with how to regulate laboratory developed tests |
Alex Philippidis |
| 47 |
[GO] |
2020―Dec―04 |
Drug Targets and Possible Treatments for Combating Multiple Coronaviruses Identified |
|
| 48 |
[GO] |
2020―Dec―04 |
SARS-CoV-2 Antibodies Decrease Three Months After Infection |
|
| 49 |
[GO] |
2020―Oct―02 |
Next-Generation Sequencing Proves Crucial in Fight Against COVID-19 |
|
| 50 |
[GO] |
2020―Oct―02 |
RNA for Medical Analysis: From Mendelian disorders to COVID-19, academic and industrial scientists use these nucleic acids to help diagnose diseases |
Mike May |
| 51 |
[GO] |
2020―Oct―02 |
Northwell Health Releases Data on COVID-19 Antibody Testing of its Frontline Staff |
|
| 52 |
[GO] |
2020―Oct―02 |
Leveraging Technology and Collaboration to Tackle the COVID-19 Pandemic: Illumina employees meet the challenge of developing an NGS-based COVID-19 diagnostic in record time while also supporting worldwide research efforts into all aspects of SARS-CoV-2 |
|
| 53 |
[GO] |
2020―Oct―02 |
AI Tool Finds Hundreds of Potential COVID-19 Drugs |
|
| 54 |
[GO] |
2020―Oct―02 |
New COVID-19 Inflammatory Response Pathway Revealed |
|
| 55 |
[GO] |
2020―Oct―02 |
NIH Launches Remdesivir Plus Interferon Beta-1a Trial for COVID-19 Treatment |
|
| 56 |
[GO] |
2020―Oct―02 |
Getting COVID-19 Vaccine and Therapeutics Right |
Chris Anderson |
| 57 |
[GO] |
2020―Oct―02 |
T Cells that Recognize SARS-CoV-2 May Be Leftover from Past Coronavirus Infections |
|
| 58 |
[GO] |
2020―Jul―31 |
Convalescent Plasma Shows Promise for Treating Serious COVID-19 |
|
| 59 |
[GO] |
2020―Jul―31 |
RNA-Seq Shows Thrombotic Complications in COVID-19 Patients Linked to Platelet Hyperreactivity |
|
| 60 |
[GO] |
2020―Jul―31 |
Building a COVID-19 Pop-Up Testing Lab: Postdocs working in the lab of Jennifer Doudna at UC Berkeley bring the testing lab online in just three weeks. |
Jennifer Hamilton |
| 61 |
[GO] |
2020―Jul―31 |
Researchers Identify Common COVID-19 Susceptibility Genes |
|
| 62 |
[GO] |
2020―Jul―31 |
Moving Beyond PCR: Next-generation sequencing enters the COVID-19 testing arena |
Julianna LeMieux |
| 63 |
[GO] |
2020―Jul―31 |
Moderna's COVID-19 Vaccine Speeds to Phase III Trial After More Positive Data |
Alex Philippidis |
| 64 |
[GO] |
2020―Jul―31 |
Asymptomatic People Infected with SARS-CoV-2 May Have Weaker Immune Response to Virus |
|
| 65 |
[GO] |
2020―Jul―31 |
Newer, Dominant SARS-CoV-2 Variant Infects at Higher Rate than Earlier Dominant Virus |
|
| 66 |
[GO] |
2020―Jun―07 |
Staying Relevant: Molecular diagnostics providers seek ways to maintain services in a world consumed by COVID-19 |
Faye Nourollahi |
| 67 |
[GO] |
2020―Jun―07 |
Rutgers Launches Prospective Study of Health Care Workers Exposed to COVID-19 |
|
| 68 |
[GO] |
2020―Jun―07 |
The First 44 FDA EUA Tests for COVID-19 |
|
| 69 |
[GO] |
2020―Jun―07 |
CRISPR Comes of Age-As a Diagnostic: Hailed for its gene editing power, Sherlock Bioscience's COVID-19 diagnostic is the first CRISPR technology to gain FDA approval |
Julianna LeMieux |
| 70 |
[GO] |
2020―Jun―07 |
The Ripple Effect of COVID-19 on Precision Medicine |
Chris Anderson |
| 71 |
[GO] |
2020―Jun―07 |
NIH to Study Impact of COVID-19 on Rare Disease Community |
|
| 72 |
[GO] |
2020―Jun―07 |
COVID-19 Precipitates Sharp Decline in Cancer Testing, Diagnoses |
|
| 73 |
[GO] |
2020―Jun―07 |
5 COVID-19 Test Developers to Watch: The coronavirus pandemic compels diagnostics companies to bring new assays, technologies to market |
Alex Philippidis |
| 74 |
[GO] |
2020―Jun―07 |
NIH Launches $1.5B Rapid COVID-19 Testing Technology Challenge |
|
| 75 |
[GO] |
2020―Jun―07 |
European Biotechs Plan Single-Dose Adenovirus COVID-19 Vaccine |
|
| 76 |
[GO] |
2020―Jun―07 |
Fully Human Antibody Discovered that Neutralizes Coronavirus |
|
| 77 |
[GO] |
2020―Jun―07 |
Iceni Diagnostics Eyes Fall Release of At-Home Coronavirus Test |
|
| 78 |
[GO] |
2020―Jun―07 |
Portable Coronavirus Test Developed Using Microfluidics and a Cell Phone |
|
| 79 |
[GO] |
2020―Jun―07 |
NIAID Study Launched to Determine SARS-CoV-2 Infection Incidence in US Children |
|
| 80 |
[GO] |
2020―Jun―07 |
Pfizer, BioNTechSE SARS-CoV-2 Vaccine Trial Launches in US |
|
